FDA — authorised 28 February 2018
- Application: NDA207962
- Marketing authorisation holder: SCILEX PHARMS
- Local brand name: ZTLIDO
- Indication: PATCH — TOPICAL
- Status: approved
🇺🇸 Lidocaine topical system 1.8% in United States
FDA authorised Lidocaine topical system 1.8% on 28 February 2018
Marketing authorisation
Frequently asked questions
Is Lidocaine topical system 1.8% approved in United States?
Yes. FDA authorised it on 28 February 2018.
Who is the marketing authorisation holder for Lidocaine topical system 1.8% in United States?
SCILEX PHARMS holds the US marketing authorisation.